Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 121 of 1,261
  1. US 11969501

    Auris formulations for treating otic diseases and conditions

    The Regents of the University of California Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  2. US 11969511

    Methods and compositions for antimicrobial treatment

    The Board of Regents of the University of Texas System Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  3. US 11970457

    Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine

    VTV THERAPEUTICS LLC Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  4. US 11970534

    Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

    The Board of Regents of the University of Texas System Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  5. US 11969424

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    TENAX THERAPEUTICS, INC. Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  6. US 11969470

    Topiramate compositions and methods of making and using the same

    Regents of the University of Minnesota Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  7. US 11971410

    Methods of classifying response to immunotherapy for cancer

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  8. US 11970711

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  9. US 11969499

    Hydrogel delivery of sting immunotherapy for treatment cancer

    The Board of Regents of the University of Texas System Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  10. US 11970554

    Labeled oxytocin and method of manufacture and use

    TONIX PHARMACEUTICALS HOLDING CORP Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  11. US 11970555

    Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

    BicycleTx Limited Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  12. US 2024131199

    PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] Β· Granted Apr 25, 2024 Β· Expires Apr 20, 2044

    granted
  13. US 11965166

    Complement factor B (CFB) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  14. US 11965190

    Vectors, genetically modified bacteria, and methods of making and using

    Regents of the University of Minnesota Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  15. US 11965159

    Compositions and methods for regulating proteins and nucleic acids activities

    The Regents of the University of California Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  16. US 11964019

    Cochleates made with soy phosphatidylserine

    MATINAS BIOPHARMA NANOTECHNOLOGIES, INC. Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  17. US 11964008

    Method for inactivating zika virus and for determining the completeness of inactivation

    Takeda Vaccines, Inc. Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  18. US 11964000

    Cancer treatment methods using nanofiber stabilized growth factors

    Northwestern University Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  19. US 11965022

    Methods and compositions for modulating CAR-T activity

    Sana Biotechnology, Inc. Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  20. US 11963958

    RET inhibitor for use in treating cancer having a RET alteration

    Rigel Pharmaceuticals, Inc. Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  21. US 11965161

    Methods and compositions for sensitization of tumor cells to immune therapy

    REGENERON PHARMACEUTICALS, INC. Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  22. US 11964960

    Pyridinone- and pyridazinone-based compounds and uses thereof

    Tri-Institutional Therapeutics Discovery Institute, Inc. Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  23. US 11964944

    Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases

    The Government of the United States Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted
  24. US 11964024

    B7H4-targeted antibody-drug conjugates and methods of use thereof

    Mersana Therapeutics, Inc. Β· Granted Apr 23, 2024 Β· Expires Apr 18, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.